Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

Nature Genetics

Volumn 45, Issue 2, 2013, Pages 180-185

  Robinson, Dan R ^a   Wu, Yi Mi ^a   Kalyana Sundaram, Shanker ^a,b   Cao, Xuhong ^a   Lonigro, Robert J ^a   Sung, Yun Shao ^c   Chen, Chun Liang ^c   Zhang, Lei ^c   Wang, Rui ^a   Su, Fengyun ^a   Iyer, Matthew K ^a,d   Roychowdhury, Sameek ^a   Siddiqui, Javed ^a   Pienta, Kenneth J ^a   Kunju, Lakshmi P ^a   Talpaz, Moshe ^a   Mosquera, Juan Miguel ^e   Singer, Samuel ^c   Schuetze, Scott M ^a   Antonescu, Cristina R ^c   Chinnaiyan, Arul M ^a,d   more..

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BHARATHIDASAN UNIVERSITY   (India)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR; STAT6 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NAB2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CELL CULTURE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FUSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SOLITARY FIBROUS TUMOR;

ADULT; BASE SEQUENCE; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DNA MUTATIONAL ANALYSIS; EXOME; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FUSION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOBLOTTING; LUCIFERASES; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY ELEMENTS, TRANSCRIPTIONAL; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOLITARY FIBROUS TUMORS; STAT6 TRANSCRIPTION FACTOR; TRANSCRIPTOME;

EID: 84873096886     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2509     Document Type: Article

References (24)

1. Roychowdhury, S. et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci. Transl. Med. 3, 111ra121 (2011).
2. Ruiz, C. et al. Advancing a clinically relevant perspective of the clonal nature of cancer. Proc. Natl. Acad. Sci. USA 108, 12054-12059 (2011).
3. Welch, J.S. et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. J. Am. Med. Assoc. 305, 1577-1584 (2011).
4. Park, M.S. & Araujo, D.M. New insights into the hemangiopericytoma/ solitary fibrous tumor spectrum of tumors. Curr. Opin. Oncol. 21, 327-331 (2009).
5. Gold, J.S. et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer 94, 1057-1068 (2002).
6. Srinivasan, R., Mager, G.M., Ward, R.M., Mayer, J. & Svaren, J. NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex. J. Biol. Chem. 281, 15129-15137 (2006).
7. Svaren, J. et al. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 16, 3545-3553 (1996).
8. Svaren, J. et al. EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J. Biol. Chem. 275, 38524-38531 (2000).
9. ENCODE Project Consortium. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9, e1001046 (2011).
10. McLean, C.Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501 (2010).
11. Hajdu, M. et al. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. J. Pathol. 221, 300-307 (2010).
12. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
13. Mosquera, J.M. & Fletcher, C.D. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component-is this dedifferentiated SFT? Am. J. Surg. Pathol. 33, 1314-1321 (2009).
14. Thiel, G. & Cibelli, G. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell. Physiol. 193, 287-292 (2002).
15. Kumbrink, J., Gerlinger, M. & Johnson, J.P. Egr-1 induces the expression of its corepressor Nab2 by activation of the Nab2 promoter thereby establishing a negative feedback loop. J. Biol. Chem. 280, 42785-42793 (2005).
16. Kumbrink, J., Kirsch, K.H. & Johnson, J.P. EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin. J. Cell. Biochem. 111, 207-217 (2010).
17. Stacchiotti, S. et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. Mol. Cancer Ther. 9, 1286-1297 (2010).
18. Aparicio, S.A. & Huntsman, D.G. Does massively parallel DNA resequencing signify the end of histopathology as we know it? J. Pathol. 220, 307-315 (2010).
19. Lonigro, R.J. et al. Detection of somatic copy number alterations in cancer using targeted exome capture sequencing. Neoplasia 13, 1019-1025 (2011).
20. Grasso, C.S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239-243 (2012).
21. Langmead, B. Aligning short sequencing reads with Bowtie. Curr. Protoc. Bioinformatics Chapter 11, Unit 11.7 (2010).
22. Iyer, M.K., Chinnaiyan, A.M. & Maher, C.A. ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics 27, 2903-2904 (2011).
23. Robinson, D.R. et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat. Med. 17, 1646-1651 (2011).
24. Yu, J. et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17, 443-454 (2010).